Her primary areas of study are Internal medicine, Breast cancer, Oncology, Cancer and Gynecology. In the field of Internal medicine, her study on Prostate cancer, Case-control study, Survival rate and Incidence overlaps with subjects such as Risk assessment. Saundra S. Buys combines subjects such as Cancer research, Genome-wide association study, Single-nucleotide polymorphism, Genetic predisposition and Family history with her study of Breast cancer.
Her work carried out in the field of Oncology brings together such families of science as Gene mutation, Ovarian cancer, Triple-negative breast cancer, Genetic testing and Risk factor. As a part of the same scientific study, Saundra S. Buys usually deals with the Cancer, concentrating on TOX3 and frequently concerns with Genetic association. Saundra S. Buys interconnects Colorectal cancer, Randomized controlled trial and Mass screening in the investigation of issues within Gynecology.
Her main research concerns Breast cancer, Internal medicine, Oncology, Cancer and Gynecology. Her Breast cancer research includes elements of Prospective cohort study, Single-nucleotide polymorphism, Family history and Cohort. Her work in the fields of Internal medicine, such as Ovarian cancer, Cancer screening, Prostate and Prostate cancer, overlaps with other areas such as Risk assessment.
Her study in Cancer screening is interdisciplinary in nature, drawing from both Randomized controlled trial and Mass screening. Her biological study deals with issues like Cancer research, which deal with fields such as Gene. Her Gynecology research is multidisciplinary, incorporating perspectives in Odds ratio, Confidence interval and Risk factor.
Saundra S. Buys mainly focuses on Breast cancer, Internal medicine, Oncology, Prospective cohort study and Family history. Her research on Breast cancer concerns the broader Cancer. Her research on Internal medicine focuses in particular on Odds ratio.
Her research in Oncology intersects with topics in Young adult, Mutation, Ovarian cancer, Hazard ratio and Prostate cancer. Her Prospective cohort study research incorporates themes from Retrospective cohort study, Natural menopause, Proportional hazards model and BRCA2 Mutation. Her Family history research incorporates elements of Psychological intervention, Gynecology and Epidemiology.
The scientist’s investigation covers issues in Breast cancer, Prospective cohort study, Risk assessment, Internal medicine and Cohort. The Breast cancer study combines topics in areas such as Obstetrics, Cancer research and Risk factor. Saundra S. Buys has researched Prospective cohort study in several fields, including Hazard ratio, Incidence, Cohort study and Family history.
Internal medicine is closely attributed to Oncology in her study. The various areas that Saundra S. Buys examines in her Oncology study include Ovarian cancer and Prostate cancer. In her research, Metabolic equivalent, Physical activity level and Body mass index is intimately related to BRCA mutation, which falls under the overarching field of Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole;E. David Crawford;Robert L. Grubb;Saundra S. Buys.
The New England Journal of Medicine (2009)
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
David J Hunter;David J Hunter;Peter Kraft;Kevin B Jacobs;David G Cox.
Nature Genetics (2007)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips.
JAMA (2017)
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S. Buys;Edward Partridge;Amanda Black;Christine C. Johnson.
JAMA (2011)
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
Gerald L. Andriole;E. David Crawford;Robert L. Grubb;Saundra S. Buys.
Journal of the National Cancer Institute (2012)
The national lung screening trial: Overview and study design
Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black.
Radiology (2011)
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy
Robert E. Schoen;Paul F. Pinsky;Joel L. Weissfeld;Lance A. Yokochi.
The New England Journal of Medicine (2012)
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
Philip C Prorok;Gerald L Andriole;Robert S. Bresalier;Saundra S Buys.
Controlled Clinical Trials (2000)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. Derose;Guoying Wang;Yi Chun Lin;Philip S. Bernard.
Nature Medicine (2011)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou;S. Casadei;T. Heikkinen;D. Barrowdale.
The New England Journal of Medicine (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Toronto
Stanford University
Fox Chase Cancer Center
Columbia University
Monash University
University of Melbourne
Cancer Council Victoria
Institute Curie
University of Utah
University of Melbourne
University of Michigan–Ann Arbor
Tsinghua University
Centrum Wiskunde & Informatica
University of Brasília
University of Science and Technology Beijing
Lawrence Livermore National Laboratory
Spanish National Research Council
University of Geneva
University of Western Australia
Mayo Clinic
Sanford Burnham Prebys Medical Discovery Institute
Utrecht University
City, University of London
Gunma University
University of Gothenburg
Southwest Research Institute